Carlyle’s $490 Million Acquisition of a Minority Stake in Piramal


Cyril Amarchand Mangaldas advised Piramal, while AZB & Partners advised Carlyle on the deal.

As reported in Legally India and in others online publications Carlyle completed the acquisition of a minority stake in Ajay Piramal’s pharma business for $490 million trumping rival private equity peers KKR and TA Associates.

Piramal Enterprises Limited provides pharmaceutical production and distribution, real estate, healthcare insights and analysis, and financial services.

The Cyril Amarchand Mangaldas team was led by partner Cyril Shroff (Picture), as well as partners Radhika Gaggar and Ruetveij Pandya.

The AZB & Partners team was led by partner Sayak Maity.

Involved fees earner: Sayak Maity – Azb & partners; Radhika Gaggar – Cyril Amarchand Mangaldas; Ruetveij Pandya – Cyril Amarchand Mangaldas; Cyril Shroff – Cyril Amarchand Mangaldas;

Law Firms: Azb & partners; Cyril Amarchand Mangaldas;

Clients: Carlyle Group; Piramal Enterprises Ltd;

Author: Michael Patrini